These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1396852)

  • 1. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.
    Motz W; Vogt M; Scheler S; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():100-6. PubMed ID: 1396852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications.
    Motz W; Vogt M; Strauer BE
    Clin Investig; 1993; 71(5 Suppl):S42-5. PubMed ID: 8518540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment in arterial hypertension for protecting hypertrophic myocardium.
    Vogt M; Motz W; Strauer BE
    Basic Res Cardiol; 1991; 86 Suppl 3():223-33. PubMed ID: 1838250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients.
    Schäfer S; Kelm M; Mingers S; Strauer BE
    J Hypertens; 2002 Jul; 20(7):1431-7. PubMed ID: 12131541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large artery function and alterations in hypertension.
    London GM
    J Hypertens Suppl; 1995 Aug; 13(2):S35-8. PubMed ID: 8576786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.